|
ECHDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
5.67829999686964E-08 |
| Normal-vs-Stage3 |
1.4830003891575E-10 |
| Normal-vs-Stage4 |
3.45499999998555E-06 |
| Stage1-vs-Stage2 |
6.326800E-01 |
| Stage1-vs-Stage3 |
6.590000E-01 |
| Stage1-vs-Stage4 |
9.226800E-01 |
| Stage2-vs-Stage3 |
4.555600E-01 |
| Stage2-vs-Stage4 |
6.826600E-01 |
| Stage3-vs-Stage4 |
8.587200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.23730051046789E-10 |
| Normal-vs-Asian |
5.572800E-04 |
| Caucasian-vs-AfricanAmerican |
1.827630E-01 |
| Caucasian-vs-Asian |
9.503400E-01 |
| AfricanAmerican-vs-Asian |
5.887000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.7625013387933E-11 |
| Normal-vs-Female |
2.9117819266844E-12 |
| Male-vs-Female |
2.305900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.13473683174925E-12 |
| Normal-vs-Extreme_Weight |
3.81072950972339E-12 |
| Normal-vs-Obese |
4.58899584998562E-11 |
| Normal-vs-Extreme_Obese |
9.52859999999722E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.198600E-01 |
| Normal_Weight-vs-Obese |
3.280200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.278000E-01 |
| Extreme_Weight-vs-Obese |
3.592100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.799400E-01 |
| Obese-vs-Extreme_Obese |
8.786200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52469999958882E-07 |
| Normal-vs-Age(41-60Yrs) |
1.09379949542188E-10 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.5919000279373E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.310800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.960600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.603800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.840200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.351400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.734600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.02119465398232E-11 |
| Normal-VS-Type2 PRCC |
3.90670051864106E-10 |
| Normal-VS-KIRP CIMP |
1.21429999999645E-06 |
| Normal-VS-Unclassified PRCC |
3.84303699973998E-12 |
| Type1 PRCC-VS-Type2 PRCC |
2.248200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.520400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.063000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.247000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.451700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.730800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.24185123190546E-13 |
| Normal-vs-N1 |
1.15939999822956E-08 |
| Normal-vs-N2 |
7.71270000000657E-05 |
| N0-vs-N1 |
3.749600E-01 |
| N0-vs-N2 |
1.758980E-01 |
| N1-vs-N2 |
5.472100E-02 |
|
|
